N-glycans on Nipah virus fusion protein protect against neutralization but reduce membrane fusion and viral entry.

Journal of Virology
Hector C AguilarBenhur Lee

Abstract

Nipah virus (NiV) is a deadly emerging paramyxovirus. The NiV attachment (NiV-G) and fusion (NiV-F) envelope glycoproteins mediate both syncytium formation and viral entry. Specific N-glycans on paramyxovirus fusion proteins are generally required for proper conformational integrity and biological function. However, removal of individual N-glycans on NiV-F had little negative effect on processing or fusogenicity and has even resulted in slightly increased fusogenicity. Here, we report that in both syncytium formation and viral entry assays, removal of multiple N-glycans on NiV-F resulted in marked increases in fusogenicity (>5-fold) but also resulted in increased sensitivity to neutralization by NiV-F-specific antisera. The mechanism underlying the hyperfusogenicity of these NiV-F N-glycan mutants is likely due to more-robust six-helix bundle formation, as these mutants showed increased fusion kinetics and were more resistant to neutralization by a fusion-inhibitory reagent based on the C-terminal heptad repeat region of NiV-F. Finally, we demonstrate that the fusogenicities of the NiV-F N-glycan mutants were inversely correlated with the relative avidities of NiV-F's interactions with NiV-G, providing support for the attachmen...Continue Reading

References

Nov 23, 1990·Science·J P MooreQ J Sattentau
Mar 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·J J SkehelD C Wiley
Oct 11, 1994·Proceedings of the National Academy of Sciences of the United States of America·C T WildT J Matthews
Nov 1, 1993·Virology·R A Lamb
Jun 12, 1998·Nature Medicine·J N ReitterR C Desrosiers
Oct 27, 1998·Computers & Chemistry·M J SchoonmanP D Grootenhuis
Mar 5, 1999·Scandinavian Journal of Infectious Diseases·S Olofsson, J E Hansen
Jun 8, 2001·Annual Review of Biochemistry·D M Eckert, P S Kim
Apr 23, 2002·Journal of Virology·Richard K PlemperRoberto Cattaneo
Nov 20, 2002·Journal of Virology·Lori W McGinnesTrudy G Morrison
Nov 22, 2002·Proceedings of the National Academy of Sciences of the United States of America·Jacqueline D ReevesRobert W Doms
Dec 6, 2002·The American Journal of Pathology·Kum Thong WongUNKNOWN Nipah Virus Pathology Working Group
Dec 28, 2002·Springer Seminars in Immunopathology·K T WongC T Tan
Mar 5, 2003·Antiviral Research·Sai-Kit Lam
Mar 21, 2003·Nature·Xiping WeiGeorge M Shaw
Jul 23, 2003·Biochimica Et Biophysica Acta·Stephen A GalloRobert Blumenthal
Jul 23, 2003·Biochimica Et Biophysica Acta·Trudy G Morrison
Sep 13, 2003·Journal of Virology·Veronika von Messling, Roberto Cattaneo
Mar 31, 2004·Proceedings of the National Academy of Sciences of the United States of America·Zhihai SiJoseph G Sodroski
May 28, 2005·Journal of Virology·James Richard CarterRebecca Ellis Dutch
Jun 21, 2005·Proceedings of the National Academy of Sciences of the United States of America·Hsien-Sheng YinTheodore S Jardetzky
Jun 24, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ernest L LevroneyBenhur Lee
Jul 7, 2005·Proceedings of the National Academy of Sciences of the United States of America·Matthew I BonaparteChristopher C Broder

❮ Previous
Next ❯

Citations

Feb 25, 2011·Expert Reviews in Molecular Medicine·Hector C Aguilar, Benhur Lee
May 16, 2009·Nature Reviews. Microbiology·Gerardo R Vasta
Sep 6, 2012·Proceedings of the National Academy of Sciences of the United States of America·Sayantan BoseRobert A Lamb
Apr 1, 2011·Journal of Virology·John B JohnsonGriffith D Parks
Jun 8, 2007·Journal of Virology·David J VigerustJonathan A McCullers
Aug 13, 2010·Journal of Virology·Everett Clinton Smith, Rebecca Ellis Dutch
Jul 27, 2007·Journal of Virology·M PorottoA Moscona
Aug 7, 2009·Journal of Virology·Tanja PaalRichard K Plemper
Sep 29, 2006·Journal of Virology·Michael J Ciancanelli, Christopher F Basler
Oct 19, 2012·Journal of Virology·Nadine AderPhilippe Plattet
Jun 10, 2011·PLoS Pathogens·Richard K PlemperRonald M Iorio
Nov 25, 2011·PLoS Pathogens·Bénédicte MachielsLaurent Gillet
May 23, 2013·PLoS Pathogens·Jonathan D Cook, Jeffrey E Lee
May 17, 2014·PLoS Pathogens·Rafael MatteraJuan S Bonifacino
Feb 18, 2010·Future Virology·Ronald M IorioPaul J Mahon
Jun 14, 2014·Proceedings of the National Academy of Sciences of the United States of America·Taylor A PoorRobert A Lamb
Oct 11, 2013·Journal of Virology·Aparna TalekarMatteo Porotto
Apr 23, 2011·Trends in Microbiology·Benhur Lee, Zeynep Akyol Ataman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.